SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. More Details
+ 2 more risks
Imperfect balance sheet with weak fundamentals.
Share Price & News
How has SQI Diagnostics's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SQD is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: SQD's weekly volatility (12%) has been stable over the past year.
7 Day Return
CA Medical Equipment
1 Year Return
CA Medical Equipment
Return vs Industry: SQD exceeded the Canadian Medical Equipment industry which returned 32.1% over the past year.
Return vs Market: SQD exceeded the Canadian Market which returned 36.9% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is SQI Diagnostics's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall StHealth Check: How Prudently Does SQI Diagnostics (CVE:SQD) Use Debt?
2 months ago | Simply Wall StAre Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?
3 months ago | Simply Wall StIs SQI Diagnostics Inc. (CVE:SQD) Popular Amongst Insiders?
Is SQI Diagnostics undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SQD's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate SQD's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: SQD is unprofitable, so we can't compare its PE Ratio to the XN Medical Equipment industry average.
PE vs Market: SQD is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SQD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SQD is overvalued based on its PB Ratio (32.8x) compared to the CA Medical Equipment industry average (7.5x).
How is SQI Diagnostics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SQI Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has SQI Diagnostics performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SQD is currently unprofitable.
Growing Profit Margin: SQD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SQD is unprofitable, and losses have increased over the past 5 years at a rate of 12.6% per year.
Accelerating Growth: Unable to compare SQD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SQD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: SQD has a negative Return on Equity (-347.25%), as it is currently unprofitable.
How is SQI Diagnostics's financial position?
Financial Position Analysis
Short Term Liabilities: SQD's short term assets (CA$5.8M) exceed its short term liabilities (CA$2.3M).
Long Term Liabilities: SQD's short term assets (CA$5.8M) exceed its long term liabilities (CA$4.8M).
Debt to Equity History and Analysis
Debt Level: SQD's debt to equity ratio (73.1%) is considered high.
Reducing Debt: SQD's debt to equity ratio has increased from 62% to 73.1% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SQD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SQD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.4% each year
What is SQI Diagnostics's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SQD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SQD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SQD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SQD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SQD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Rob Chioini (55 yo)
Mr. Robert L. Chioini, also known as Rob, founded Rockwell Medical, Inc. (also known as, Rockwell Medical Technologies Inc) and served as its Chief Executive Officer from February 1997 to May 22, 2018. He ...
CEO Compensation Analysis
Compensation vs Market: Rob's total compensation ($USD51.45K) is below average for companies of similar size in the Canadian market ($USD156.82K).
Compensation vs Earnings: Insufficient data to compare Rob's compensation with company performance.
Experienced Management: SQD's management team is considered experienced (2.4 years average tenure).
Experienced Board: SQD's board of directors are considered experienced (6.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SQD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.
SQI Diagnostics Inc.'s company bio, employee growth, exchange listings and data sources
- Name: SQI Diagnostics Inc.
- Ticker: SQD
- Exchange: TSXV
- Founded: 1999
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$101.094m
- Shares outstanding: 342.69m
- Website: https://www.sqidiagnostics.com
Number of Employees
- SQI Diagnostics Inc.
- 36 Meteor Drive
- M9W 1A4
SQI Diagnostics Inc., a precision medicine company, discovers, develops, produces, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The comp...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/08 06:53|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.